Vertex Pharmaceuticals Inc at Leerink Global Healthcare Conference Transcript
Welcome everyone to our session with Vertex. It's very much my pleasure to welcome members of the leadership team on the screen if you're in the room. Duncan has been re-titled as CSO, I guess that's in the wake of the positive Pove data, trying to take credit for that. So he's out of a title. But to my immediate left is Charlie Wagner, company's COO and CFO; and Duncan McKechnie is to his left, Chief Commercial Officer; and Susie Lisa, Senior Vice President of Investor Relations to Duncan's left.
So, thank you very much for being here. Great timing. Thanks for issuing the press release last night ahead of conference for you. So why don't we start with [Pove]? It would be great to hear how we view the data and then we'll go from there.
If you don't mind, I'd like to make just a couple of general remarks too, and then we will, of course, dive into that. Anyways, thank you for hosting us this year. We came into 2026 with four primary goals for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
